These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21478285)

  • 21. The lupus anticoagulant in systemic lupus erythematosus.
    Rowell NR; Tate GM
    Acta Derm Venereol; 1989; 69(2):111-5. PubMed ID: 2564226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatitis in systemic lupus erythematosus: frequency and associated factors - a review of the Hopkins Lupus Cohort.
    Makol A; Petri M
    J Rheumatol; 2010 Feb; 37(2):341-5. PubMed ID: 20032096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
    Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
    Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E; Magder LS; Petri M
    J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moderate and severe neutropenia in patients with systemic lupus erythematosus.
    Martínez-Baños D; Crispín JC; Lazo-Langner A; Sánchez-Guerrero J
    Rheumatology (Oxford); 2006 Aug; 45(8):994-8. PubMed ID: 16484291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons from the "Euro-Lupus Cohort".
    Cervera R; Abarca-Costalago M; Abramovicz D; Allegri F; Annunziata P; Aydintug AO; Bacarelli MR; Bellisai F; Bernardino I; Biernat-Kaluza E; Blockmans D; Boki K; Bracci L; Campanella V; Camps MT; Carcassi C; Cattaneo R; Cauli A; Chwalinska-Sadowska H; Contu L; Cosyns JP; Danieli MG; D'Cruz D; Depresseux G; Direskeneli H; Domènech I; Espinosa G; Fernández-Nebro A; Ferrara GB; Font J; Frutos MA; Galeazzi M; García-Carrasco M; García-Iglesias MF; García-Tobaruela A; George J; Gil A; González-Santos P; Grana M; Gül A; Haga HJ; de Haro-Liger M; Houssiau F; Hughes GR; Ingelmo M; Jedryka-Góral A; Khamashta MA; Lavilla P; Levi Y; López-Dupla M; López-Soto A; Maldykowa H; Marcolongo R; Mathieu A; Morozzi G; Nicolopoulou N; Papasteriades C; Passiu G; Perelló I; Petera P; Petrovic R; Piette JC; Pintado V; de Pita O; Popovic R; Pucci G; Puddu P; de Ramón E; Ramos-Casals M; Rodríguez-Andreu J; Ruiz-Irastroza G; Sánchez-Lora J; Sanna G; Scorza R; Sebastini GD; Sherer Y; Shoenfeld Y; Simpatico A; Sinico RA; Smolen J; Tincani A; Tokgöz G; Urbano-Márquez A; Vasconcelos C; Vázquez JJ; Veronesi M; Vianni J; Vivancos J;
    Ann Med Interne (Paris); 2002 Dec; 153(8):530-6. PubMed ID: 12610427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-tuberculous mycobacterial infection in patients with systemic lupus erythematosus.
    Mok MY; Wong SS; Chan TM; Fong DY; Wong WS; Lau CS
    Rheumatology (Oxford); 2007 Feb; 46(2):280-4. PubMed ID: 16861709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of granulopoiesis with severe neutropenia in systemic lupus erythematosus.
    Arenas M; Abad A; Valverde V; Ferriz P; Pascual R
    Arthritis Rheum; 1992 Aug; 35(8):979-80. PubMed ID: 1642663
    [No Abstract]   [Full Text] [Related]  

  • 30. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan.
    Chen YJ; Chang YT; Wang CB; Wu CY
    Am J Med; 2010 Dec; 123(12):1150.e1-6. PubMed ID: 21183006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late onset systemic lupus erythematosus: a new approach.
    Karoubi Nordon E; Hayem G; Mentres F; Palazzo E; Legrain S; Meyer O; Raveau P
    Lupus; 2007; 16(12):1011-4. PubMed ID: 18042600
    [No Abstract]   [Full Text] [Related]  

  • 32. Coronary artery bypass grafting in patients with systemic lupus erythematosus.
    Bossert T; Falk V; Gummert JF; Rahmel A; Mohr FW
    Z Kardiol; 2003 Mar; 92(3):219-21. PubMed ID: 12658468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus.
    O'Neill SG; Pego-Reigosa JM; Hingorani AD; Bessant R; Isenberg DA; Rahman A
    Rheumatology (Oxford); 2009 May; 48(5):573-5. PubMed ID: 19273540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus.
    Goldberg RJ; Urowitz MB; Ibañez D; Nikpour M; Gladman DD
    J Rheumatol; 2009 Nov; 36(11):2454-61. PubMed ID: 19833754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001--2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study).
    Tamayo T; Fischer-Betz R; Beer S; Winkler-Rohlfing B; Schneider M
    Lupus; 2010 Dec; 19(14):1606-13. PubMed ID: 20829309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Memory impairment associated with neurometabolic abnormalities of the hippocampus in patients with non-neuropsychiatric systemic lupus erythematosus.
    Kozora E; Brown MS; Filley CM; Zhang L; Miller DE; West SG; Pelzman J; Arciniegas DB
    Lupus; 2011 May; 20(6):598-606. PubMed ID: 21335397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group.
    Nived O; Sturfelt G; Wollheim F
    Q J Med; 1985 Jun; 55(218):271-87. PubMed ID: 4023171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early renal damage assessed by the SLICC/ACR damage index is predictor of severe outcome in lupus patients in Pakistan.
    Rabbani MA; Habib HB; Islam M; Ahmad B; Shah SM; Tahir S; Merchant D; Ahmad A
    Lupus; 2010 Nov; 19(13):1573-8. PubMed ID: 20705644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors of mortality for salmonella infection in systemic lupus erythematosus.
    Tsao CH; Chen CY; Ou LS; Huang JL
    J Rheumatol; 2002 Jun; 29(6):1214-8. PubMed ID: 12064838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent systemic lupus erythematosus and salmonellosis.
    Lovy MR; Ryan PF; Hughes GR
    J Rheumatol; 1981; 8(4):605-12. PubMed ID: 7299762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.